To order this detailed 290+ page report, please visit this link
Key Inclusions
§ A detailed review ofthe overall landscape of companies offering proteome profiling services, alongwith information on type of service provider (industry and non-industry), yearof establishment, company size, location of headquarters, service(s) offeredfor pre-proteome profiling (protein identification, protein quantification,protein separation, protein extraction and protein purification), service(s)offered for proteome profiling (analysis of post translational modifications,protein characterization, in silico analysis and protein sequencing), otherservice(s) offered (protein-protein interaction analysis, biomarker discovery,biological pathway identification, impurity profile analysis, bio imaging ofproteins), type of product profiled (proteins and peptides), type of sample(s)used (cells, tissues, plasma, serum, urine, cerebrospinal fluid (d), blood,saliva, cyst fluid and others) and type of application (drug discovery, diseasediagnosis and others).
§ Elaborate profiles ofthe prominent players (shortlisted based on a proprietary criterion) acrossNorth America, Europe and Asia Pacific and rest of the world. Each profileincludes a brief overview of the company, its year of establishment, locationof headquarters, number of employees and financial information (if available).In addition to this, the profile includes information on the proteome profilingservices offered by the company, along with information on the proteomeprofiling technologies used. Further, we have provided the recent developmentsof the company and an informed future outlook.
§ A competitivenessanalysis of proteome profiling service providers, taking into consideration thesupplier strength (based on company size and its experience in this field),service strength (based on number of pre-proteome profiling service(s) offered,number of proteome profiling service(s) offered, number of other service(s)offered, number of product types profiled and number of applications) andnumber of samples profiled (which is depicted by size of the bubble).
§ An analysis of thepartnerships that have been inked by stakeholders in the proteome profilingservices domain, during the time period 2014-2020 (till April), coveringdifferent partnership models, such as service alliances, acquisitions,technology licensing, R&D agreements and research agreements.
§ An elaboratediscussion on various factors contributing to the high price of proteomeprofiling. It features different pricing models of proteome profiling servicesbased on number of proteins / samples processed, proteome profiling steps andsample types.
§ A discussion onaffiliated trends, key drivers and challenges which are likely to impact theindustry's evolution, under a comprehensive SWOT framework; it includes aHarvey ball analysis, highlighting the relative effect of each SWOT parameteron the overall industry.
§ A detailed review ofthe impact of the COVID-19 pandemic on the overall proteome profiling servicesmarket. In addition, it features various strategies that different companieshave adopted / might adopt in order to mitigate the challenges affiliated tothe current global crisis.
The report also features the likelydistribution of the current and forecasted opportunity across important marketsegments, mentioned below:
- Application Area
- Drug Discovery
- Disease Diagnosis
- Others
- Type of Sponsor(s)
- Contract Research Organizations
- Pharmaceutical Companies
- Research and Academic Institutes
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Rest of the World
Thereport features inputs from eminent industry stakeholders, according to whom,in terms of application area, the market for proteome profiling servicesintended for disease diagnosis is likely to grow at a relatively faster pace.The report includes detailed transcripts of discussions held with the followingexperts:
- James Fedrick (President and Chief Executive Officer, Rockland Immunochemicals)
- Anton Iliuk (Chief Technology Officer, Tymora Analytical Operations)
To request sample pages, please visit this link
Key Questions Answered
§ Who are the leadingproteome profiling service providers?
§ What are the key challengesfaced by proteome profiling service providers?
§ What kind ofpartnership models are most commonly adopted by industry stakeholders?
§ What are the keyperformance indicators used by sponsors to evaluate potential serviceproviders?
§ How is the recent COVID-19pandemic likely to impact the demand for proteome profiling services?
§ What factors are anticipatedto influence the evolution of the proteome profiling market?
§ How is the currentand future opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
1. Peptides andMacrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030
2. Peptide Therapeutics:Contract API Manufacturing Market, 2020 - 2030
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
